Andrew Cheng's Net Worth
$34.3 Million
Who is Andrew Cheng?
Andrew Cheng has an estimated net worth of $34.3 Million. This is based on reported shares across multiple companies, which include Vera Therapeutics, Inc., Arbutus Biopharma Corp, and Akero Therapeutics, Inc..
SEC CIK
Andrew Cheng's CIK is 0001778307
Past Insider Trading and Trends
2023 was Andrew Cheng's most active year for acquiring shares with 20 total transactions. Andrew Cheng's most active month to acquire stocks was the month of November. 2023 was Andrew Cheng's most active year for disposing of shares, totalling 55 transactions. Andrew Cheng's most active month to dispose stocks was the month of February. 2024 saw Andrew Cheng paying a total of $1,348,969.79 for 154,602 shares, this is the most they've acquired in one year. In 2023 Andrew Cheng cashed out on 655,585 shares for a total of $12,341,903.97, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Vera Therapeutics, Inc. (VERA) Snapshot price: $37.2
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 4
|
∞
| 17.49K |
—
|
—
| 17.49K |
May 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Arbutus Biopharma Corp (ABUS) Snapshot price: $4.5488
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Akero Therapeutics, Inc. (AKRO) Snapshot price: $26.41
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$26.42 | -$1,151,789.47 | 605.42K |
Nov 1
| |||
Form 4
|
—
|
0
|
$26.26 | -$944,560.74 | 605.42K |
Oct 16 - Oct 18
| |||
Form 4
| -0.29% | -1.74K |
$26.18 | -$45,500.84 | 605.42K |
Sep 10
| |||
Form 4
| +4.21% | 24.54K |
$0.62 | $15,090.87 | 607.15K |
Aug 16
| |||
Form 4
| +0.18% | 1.06K |
$19.94 | $21,217.22 | 582.62K |
Jun 28
| |||
Form 4
| -1.34% | -7.89K |
$22.64 | -$178,728.05 | 581.55K |
Jun 11
| |||
Form 4
| -0.33% | -1.97K |
$28.33 | -$55,781.77 | 589.45K |
Mar 13
| |||
Form 4
|
—
|
0
|
$25.02 | -$1,177,001.57 | 591.42K |
Mar 4
| |||
Form 4
| +7.26% | 40K |
$0.62 | $24,600.00 | 590.91K |
Jan 2
| |||
Form 4
| -0.29% | -1.63K |
$20.76 | -$33,797.28 | 550.91K |
Dec 14
| |||
Form 4
| +19.86% | 91.54K |
$13.19 | -$368,388.45 | 552.54K |
Dec 7 - Dec 11
| |||
Form 4
|
—
|
0
|
$27.14 | -$1,038,827.32 | 461K |
Oct 2
| |||
Form 4
| -0.36% | -1.68K |
$50.34 | -$84,671.88 | 461K |
Sep 13
| |||
Form 4
|
—
|
0
|
$28.07 | -$1,085,247.51 | 462.68K |
Sep 1
| |||
Form 4
| +3.35% | 15K |
$0.62 | $9,225.00 | 462.68K |
Aug 30
| |||
Form 4
|
—
|
0
|
$24.76 | -$919,866.67 | 447.68K |
Aug 1
| |||
Form 4
|
—
|
0
|
$25.62 | -$963,041.00 | 447.68K |
Jul 3
| |||
Form 4
| +9.81% | 40K |
$0.62 | $24,600.00 | 447.68K |
Jun 27
| |||
Form 4
| -0.39% | -1.61K |
$55.16 | -$88,973.08 | 407.68K |
Jun 13
| |||
Form 4
|
—
|
0
|
$23.28 | -$1,090,971.14 | 409.29K |
Jun 1
| |||
Form 4
| +10.83% | 40K |
$22.85 | -$1,086,884.61 | 409.29K |
Apr 18 - May 1
| |||
Form 4
|
—
|
0
|
$19.28 | -$933,201.00 | 369.29K |
Apr 3
| |||
Form 4
| -0.46% | -1.71K |
$43.47 | -$74,159.82 | 369.29K |
Mar 10
| |||
Form 4
|
—
|
0
|
$23.64 | -$1,150,963.49 | 371K |
Scheduled
|
Mar 1
| ||
Form 4
|
—
|
0
|
$24.84 | -$1,211,020.24 | 371K |
Scheduled
|
Feb 1
| ||
Form 4
|
—
|
0
|
$25.95 | -$1,266,376.25 | 371K |
Scheduled
|
Jan 3
| ||
Form 4
| +2.34% | 8.5K |
$0.62 | $5,227.50 | 371K |
Dec 16
| |||
Form 4
| +16.88% | 52.35K |
—
|
—
| 362.5K |
Dec 9
| |||
Form 4
|
—
|
0
|
$23.35 | -$454,550.00 | 310.15K |
Scheduled
|
Dec 1
| ||
Form 4
|
—
|
0
|
$22.02 | -$428,033.00 | 310.15K |
Scheduled
|
Nov 1
| ||
Form 4
|
—
|
0
|
$16.92 | -$326,128.50 | 310.15K |
Scheduled
|
Oct 3
| ||
Form 4
|
—
|
0
|
$14.02 | -$1,608,543.80 | 310.15K |
Scheduled
|
Sep 13
| ||
Form 4
| +0.37% | 1.15K |
$8.03 | $9,250.56 | 310.15K |
Jun 30 - Sep 13
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
$9.11 | -$169,750.00 | 309K |
Scheduled
|
Mar 1
| ||
Form 4
|
—
|
0
|
$9.09 | -$169,450.00 | 309K |
Scheduled
|
Feb 1
| ||
Form 4
|
—
|
0
|
$10.09 | -$189,350.00 | 299K |
Scheduled
|
Jan 10 - Jan 10
| ||
Form 4
| +20.70% | 53K |
$0.62 | $32,595.00 | 309K |
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 8
| |||
Form 4
| -6.40% | -17.50K |
$20.18 | -$353,150.00 | 256K |
Scheduled
|
Dec 2
| ||
Form 4
| -6.01% | -17.50K |
$22.57 | -$394,975.00 | 273.5K |
Scheduled
|
Nov 2
| ||
Form 4
| -5.67% | -17.50K |
$21.54 | -$376,950.00 | 291K |
Scheduled
|
Oct 4
| ||
Form 4
| -5.37% | -17.50K |
$23.89 | -$418,075.00 | 308.5K |
Scheduled
|
Sep 2
| ||
Form 4
| -5.09% | -17.50K |
$20.83 | -$364,577.00 | 326K |
Scheduled
|
Aug 3
| ||
Form 4
| -4.86% | -17.50K |
$24.78 | -$433,650.00 | 342.49K |
Scheduled
|
Jul 2
| ||
Form 4
| +4.96% | 17K |
$0.62 | $12,300.00 | 359.99K |
Dec 31 - Jan 7
| |||
Form 4
| +2.23% | 7.48K |
$0.62 | $4,637.60 | 342.99K |
Dec 28
| |||
Form 4
| +2.43% | 7.95K |
$0.62 | $6,510.00 | 335.51K |
Dec 11 - Dec 21
| |||
Form 4
| +0.38% | 1.25K |
$17.07 | $21,249.66 | 327.56K |
Jun 30 - Dec 8
| |||
Form 4
| +0.32% | 1.02K |
$18.87 | $19,337.65 | 326.31K |
Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||